Non-alcoholic fatty liver disease resolution following sleeve gastrectomy

Surgical Endoscopy

Volumn 30, Issue 5, 2016, Pages 1983-1987

  Algooneh, Ardeshir ^a   Almazeedi, Sulaiman ^a   Al Sabah, Salman ^a   Ahmed, Maha ^a   Othman, Feras ^a  

^a AL AMIRI HOSPITAL   (Kuwait)

Author keywords

Bariatric; Metabolic surgery; NAFLD; Obesity; Sleeve gastrectomy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEVE GASTRECTOMY; WEIGHT REDUCTION; BARIATRIC SURGERY; COMPLICATION; DIAGNOSTIC IMAGING; ECHOGRAPHY; FOLLOW UP; GASTRECTOMY; LAPAROSCOPY; LIVER; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, MORBID; POSTOPERATIVE PERIOD; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BARIATRIC SURGERY; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LAPAROSCOPY; LIVER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRASONOGRAPHY; WEIGHT LOSS; YOUNG ADULT;

EID: 84937597919     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-015-4426-0     Document Type: Article

References (27)

1. Lee D (2007) Obesity can lead to fatty liver a silent killer, editorial review Aug 2007. http://www.medicinenet.com/script/main/art.asp?articlekey=46582. Accessed 15 Feb 2015
2. Angulo P (2007) GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25:883–889
3. Law K, Brunt E (2010) Nonalcoholic fatty liver disease. Clin Liver Dis 14:591–604
4. Oh M, Winn J, Poordad F (2008) Review article: diagnosis and treatment of nonalcoholic fatty liver disease. Aliment Pharmacol Ther 28(5):503–522
5. Vernon G, Baranova A, Younossi Z (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285
6. Day C (2011) Non-alcoholic fatty liver disease: a massive problem. Clin Med 11:176–178
7. Zelber-Sagi S, Ratziu V, Oren R (2011) Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 17:3377–3389
8. Adams L, Feldstein A (2010) Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Rev Gastroenterol Hepatol 4:623–635
9. Lonardo A, Lombardini S, Ricchi M et al (2005) Review article: hepatic steatosis and insulin resistance. Aliment Pharmacol Ther 22(Suppl. 2):64–70
10. Krawczyk M, Bonfrate L, Portincasa P (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24:695–708
11. Lonardo A, Bellentani S, Ratziu V et al (2011) Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient—death of a dogma from analysis of therapeutic studies? Expert Rev Gastroenterol Hepatol 5:279–289
12. American liver foundation. Non alcoholic fatty liver disease. January 2015. http://www.liverfoundation.org/abouttheliver/info/nafld. Accessed 20 Feb 2015
13. Sasaki A, Nitta H, Otsuka K (2014) Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments. October 2014. http://journal.frontiersin.org/article/10.3389/fendo.2014.00164/full. Accessed 20 Feb 2015
14. Digestive Disease Week. Weight-loss surgery can reduce liver damage: study shows reversal of early-stage liver fibrosis after bariatric surgery. May 2014. http://www.ddw.org/news/articles/2014/05/06/weight-loss-surgery-can-reduce-liver-damage. Accessed 20 Feb 2015
15. Chalasani N, Younossi Z, Lavine J et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55(6):2005–2023
16. Johnson B, Blackhurst D, Latham B et al (2013) Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg 216(4):545–556; discussion 556–558
17. Freedman D, Ron E, Ballard-Barbash R et al (2006) Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond) 30(5):822–829
18. Vogel J, Franklin B, Zalesin K (2007) Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol 99(2):222–226
19. Karcz W, Krawczykowski D, Kuesters S et al (2011) Influence of sleeve gastrectomy on NASH and type 2 diabetes mellitus. J Obes 765473
20. Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51(2):679–689
21. Dixon J, Bhathal P, Hughes N et al (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39(6):1647–1654
22. Chavez-Tapia N, Tellez-Avila F, Barrientos-Gutierrez T et al (2010) Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev 20(1):CD007340
23. Mattar S, Velcu L, Rabinovitz M et al (2005) Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242(4):610–617
24. Taitano A, Markow M, Finan J et al (2015) Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg 19(3):429–437
25. Vuppalanchi R, Chalasan N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49(1):306–317
26. Aithal G, Thomas J, Kaye P et al (2008) Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 135(4):1176–1184
27. Mathurin P, Gonzalez F, Kerdraon O et al (2006) The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 130(6):1617–1624